Discussing whether foods DETAILColin O'Neil, The Center For Food Safety, and Mark Connelly, CLSA analyst.
Consumer Reports says 48 million people get sick from salmonella every year. CNBC's Jane Wells reports Consumer Reports tested more than 300 chicken breasts bought across the U.S., and found bacteria in nearly all of them.
Secretary of Agriculture Tom Vilsack discusses the government's plan to help save millions of acres from citrus greening disease.
The search for a pill that boosts sexual desire in women has hit another roadblock, raising questions about future of female libido drugs.
The Food and Drug Administration is phasing out the use of antibiotics in meat over concerns about antibiotic-resistant bacteria.
Focused on high-risk heart attack and stroke patients, the new recommendation are for aggressive drug therapy to lower cholesterol.
The move to ban trans fats could prevent 20,000 heart attacks a year and 7,000 deaths, FDA Commissioner Margaret Hamburg said.
How are biotech companies and the FDA impacted by the government shutdown? Yaron Werber of Citi Investment Research, offers insight.
Up 54% ytd, if pros must buy health care, Cramer thinks they’ll take a long hard look at this stock.
Current and ex-law enforcement officials warn that a menthol cigarette ban could spark a black market boom in the smokes.
Microsoft CEO Steve Ballmer is giving a 12-month notice of his retirement, and the FDA is considering a ban on online sales of e-cigarettes. CNBC's John Carney and Simon Hobbs discuss.
Leonard Schleifer, Regeneron Pharmaceuticals president and CEO, breaks down the company's better-than-expected earnings, and positive results from its phase three trials of a drug designed to improve vision in patients with diabetic macular edema.
A Food and Drug Administration review concludes that menthol cigarettes pose a greater public health risk than regular cigarettes.
The Supreme Court ruled that makers of generic drugs already approved by the FDA cannot be held liable under state law for claims of design defects.
A dispute within the FDA on whether to put new lung-cancer warnings on ARBs taken by millions of people is unlikely to have any significant effect on the manufacturers stocks.
Cramer has been looking at long-term losers to see if any show potential. He’s found something.
CFO Simon Dingemans says GlaxoSmithKline's re-engineered approach to R&D is bearing fruit.
An antibiotic-resistant strain of gonorrhea has some saying that its effects could match those of AIDS.
The FDA has lowered the age limit for Plan B One-Step emergency contraceptive to 15. The pill will be available without a prescription and stocked on store shelves.
Big pharma is abandoning antibiotic research at a time when fears over superbugs are growing at an alarming rate, leaving smaller firms to fill the breach.